LUCIFERIN DERIVATE

European patent · EP2981527 · In force

Register entry

Publication number
EP2981527
Application number
EP14717070
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 7, 2014
Published
Feb 10, 2016
Granted
Oct 31, 2018
Protection ends at the latest
Apr 6, 2034
Next annual fee due
Apr 30, 2026
IPC classes
C07D 277/64 (2006.01)
C12Q 1/66 (2006.01)
Priority
GB 201306248 05.04.2013
PCT application
PCT/GB2014/051080 07.04.2014
PCT publication
WO2014/162157 09.10.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 14, 2025

    Change

    Published in Swissreg on 14.10.2025

  2. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  3. Oct 31, 2023

    Change

    Published in Swissreg on 31.10.2023

  4. May 8, 2023

    Address changed

    Representative
    Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel → VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 08.05.2023

  5. Mar 20, 2019

    Address changed

    Representative
    Valipat S.A., Gevers SA, Rue des Noyers 11, 2000 Neuchâtel → Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel

    Published in Swissreg on 20.03.2019

  6. Dec 15, 2018

    Agent entered

    Representative
    Valipat S.A., Gevers SA, Rue des Noyers 11, 2000 Neuchâtel

    Published in Swissreg on 15.12.2018

  7. Oct 31, 2018

    Granted

    Published in Swissreg on 31.10.2018

Parties

Inventor

GROUNDS, Helen

London SE21 8HP, GB

PULE, Martin A.

London W1T 4TP, GB

ANDERSON, James C.

Nottingham NG13 0FE, GB

JATHOUL, Amit P.

London W1T 4TP, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.